StemCell Therapy

DUBLIN, June 18, 2020 /PRNewswire/ -- The "Stem Cell Therapy Market to 2027 - Global Analysis and Forecasts by Type; Treatment; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The stem cell therapy market was valued at US$ 1,534.55 million in 2019 and is estimated to reach US$ 5,129.66 million by 2027; it is expected to grow at a CAGR of 16.7% from 2020 to 2027.

The increasing awareness related to the stem cells therapy in effective disease management and growing demand for regenerative medicines are the key factor driving the stem cell therapy market. However, high cost related of the stem cell therapy limits the growth of the market.

Stem cell research has been widely investigated globally for various medical applications, especially for the treatment of humans. This raises the importance of creating public awareness about stem cell research and its clinical potential. The main role of stem cells is in the replacement of dying cells and reconstruction of damaged tissues. Based on the extensive stem cell research, many scientists have claimed that these cells could probably be used in the treatment of various diseases, including cancer and cardiovascular disease.

There is a large number of potential treatment procedures that are undergoing clinical trials, and a notably few stem cell therapies have won FDA (i.e., US -Food and Drug Administration) approval for clinical usage. For instance, in 2019, the FDA approved Fedratinib for the first-line treatment for myelofibrosis. Moreover, stem cell therapies are widely used in bone marrow transplantation, and these therapies have benefited thousands of people suffering from leukemia. Hematopoietic stem cells are used for treating more than 80 medical diseases, including immune system disorders, blood disorders, neurological disorders, metabolic disorders, genetic disorders, and several types of cancers, such as leukemia and lymphoma; this is also likely to boost the demand for this treatment procedure during the forecast period. Researchers are further investigating the use of stem cell therapies in the treatment of autoimmune disorders.

The global stem cell therapy market has been segmented on the basis of type, treatment, application type, and end user. Based on type, the market has been segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and others. The adult stem cell therapy held the largest share of the market in 2019; however, induced pluripotent stem cell therapy is estimated to register the highest CAGR in the market during the forecast period. Based on treatment, the stem cell therapy market has been segmented into allogeneic and autologous. The allogeneic segment held a larger share of the market in 2019; however, the market for the autologous segment is expected to grow at a higher CAGR during the forecast period.

Reasons to Buy:

Key Topics Covered:

1. Introduction1.1 Scope of the Study1.2 Report Guidance1.3 Market Segmentation1.3.1 Global Stem Cell Therapy Market - By Type1.3.2 Global Stem Cell Therapy Market - By Treatment1.3.3 Global Stem Cell Therapy Market - By Application1.3.4 Global Stem Cell Therapy Market - By End User1.3.5 Global Stem Cell Therapy Market - By Geography

2. Stem Cell Therapy Market - Key Takeaways

3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research

4. Stem Cell Therapy - Market Landscape4.1 Overview4.2 PEST Analysis4.2.1 North America4.2.2 Europe4.2.3 Asia Pacific4.2.4 Middle East & Africa4.2.5 South and Central America4.3 Expert Opinion

5. Stem Cell Therapy Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Awareness Related to the Stem Cells Therapy in Effective Disease Management5.1.2 Growing Demand For Regenerative Medicines5.1.3 Growing Cancer Prevalence Across The Globe5.2 Market Restraints5.2.1 High Cost Related with Stem Cell Therapy5.3 Market Opportunities5.3.1 Growth in the Global Healthcare Market5.4 Future Trends5.4.1 Research Activities and Product Innovations5.5 Impact Analysis

6. Stem Cell Therapy Market - Global Analysis6.1 Global Stem Cell Therapy Market Revenue Forecast And Analysis6.2 Global Stem Cell Therapy Market, By Geography - Forecast And Analysis6.3 Market Positioning of Key Players

7. Global Stem Cell Therapy Market Analysis- by Type7.1 Overview7.2 Stem Cell Therapy Market Revenue Share, by Type (2019 and 2027)7.3 Adult Stem Cell Therapy7.3.1 Overview7.3.2 Adult Stem Cell Therapy : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.3.3 Hematopoietic Stem Cell Therapy7.3.3.1 Overview7.3.3.2 Hematopoietic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.3.4 Umbilical Cord Stem Cell Therapy7.3.4.1 Overview7.3.4.2 Umbilical Cord Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.3.5 Neuronal Stem Cell Therapy7.3.5.1 Overview7.3.5.2 Neuronal Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.3.6 Mesenchymal Stem Cell7.3.6.1 Overview7.3.6.2 Mesenchymal Stem Cell: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.4 Induced Pluripotent Stem Cell Therapy7.4.1 Overview7.4.2 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.4.3 Induced Pluripotent Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.5 Embryonic Stem Cell Therapy7.5.1 Overview7.5.2 Embryonic Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)7.6 Other Stem Cell Therapy7.6.1 Overview7.6.2 Other Stem Cell Therapy: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

8. Stem Cell Therapy Market Analysis- by Treatment8.1 Overview8.2 Stem Cell Therapy Market, by Treatment 2019 and 2027 (%)8.3 Allogeneic8.3.1 Overview8.3.2 Allogeneic: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)8.4 Autologous8.4.1 Overview8.4.2 Autologous: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

9. Stem Cell Therapy Market Analysis - by Application9.1 Overview9.2 Stem Cell Therapy Market Revenue Share, by Application (2019 and 2027)9.3 Musculoskeletal9.3.1 Overview9.3.2 Musculoskeletal: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)9.4 Dermatology9.4.1 Overview9.4.2 Dermatology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)9.5 Cardiology9.5.1 Overview9.5.2 Cardiology: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)9.6 Drug Discovery and Development9.6.1 Overview9.6.2 Drug Discovery and Development: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)9.7 Other Applications9.7.1 Overview9.7.2 Other Applications: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

10. Stem Cell Therapy Market Analysis- by End User10.1 Overview10.2 Stem Cell Therapy Market, by End User 2019 and 2027 (%)10.3 Academic & Research Institutes10.3.1 Overview10.3.2 Academic & Research Institutes: Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)10.4 Hospitals & Specialty Clinics10.4.1 Overview10.4.2 Hospitals & Specialty Clinics : Stem Cell Therapy Market - Revenue and Forecast to 2027 (US$ Million)

11. Stem Cell Therapy Market - Geographic Analysis11.1 North America: Stem Cell Therapy Market11.2 Europe: Stem Cell Therapy Market11.3 Asia Pacific: Stem Cell Therapy Market11.4 Middle East & Africa: Stem Cell Therapy Market11.5 South and Central America: Stem Cell Therapy Market

12. Stem Cell Therapy Market -Industry Landscape12.1 Overview12.2 Growth Strategies In The Stem Cell Therapy Market, 2015-201912.3 Organic Growth Strategies12.3.1 Overview12.4 Inorganic Growth Strategies12.4.1 Overview

13. COMPANY PROFILES13.1 MEDIPOST13.1.1 Key Facts13.1.2 Business Description13.1.3 Products and Services13.1.4 Financial Overview13.1.5 SWOT Analysis13.1.6 Key Developments13.2 Pharmicell Co., Inc.13.3 RichSource13.4 BioTime Inc. (Lineage Cell Therapeutics, Inc.)13.5 Mesoblast Limited13.6 Holostem Terapie Avanzate Srl13.7 U.S. Stem Cell, Inc.13.8 Caladrius Biosciences, Inc.13.9 TiGenix NV13.10 AlloSource

For more information about this report visit https://www.researchandmarkets.com/r/m8jwr5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Read more from the original source:
Worldwide Stem Cell Therapy Industry to 2027 - Growth in the Global Healthcare Market Presents Opportunities - PRNewswire

This entry was posted on June 19, 2020 at 4:50 am and is filed under Stem Cell Therapy. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |